La epidemiología la vincula con varios tipos de neoplasias | 09 JUL 17

¿Cuál es el efecto de la obesidad sobre el cáncer?

La obesidad es uno de los mayores problemas de salud pública. La evidencia sobre la solidez de los riesgos asociados podría identificar mejor a las personas con alto riesgo de cáncer, quienes podrían así recibir prevención personalizada
Autor/a: Kyrgiou M, Kalliala I,Markozannes G BMJ 2017;356:j477
INDICE:  1. Página 1 | 2. Referencias bibliográficas
Referencias bibliográficas

Referencias bilibiográficas

1 Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893-917. doi:10.1002/ijc.25516.

2 Dixon JB. The effect of obesity on health outcomes. Mol Cell Endocrinol 2010; 316:104-8. doi:10.1016/j.mce.2009.07.008.

3 Stevens GA, Singh GM, Lu Y, et al. Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Body Mass Index). National, regional, and global trends in adult overweight and obesity prevalences. Popul Health Metr 2012; 10:22.


4 NCD Risk Factor Collaboration (NCD-RisC). Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19・2 million participants. Lancet 2016; 387:1377-96.

5 Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014; 384:766-81. doi:10.1016/


6 Marmot M, Atinmo T, Byers T, et al. Food, nutrition, physical activity, and the prevention of cancer: a global perspective.World Cancer Research Fund/ American Institute for Cancer Research, 2007.

7 Ioannidis JP. Why most discovered true associations are inflated. Epidemiology 2008;19:640-8. doi:10.1097/EDE.0b013e31818131e7.

8 Ioannidis JP. Why most published research findings are false. PLoS Med 2005;2:e124. doi:10.1371/journal.pmed.0020124.

9 Dwan K, Gamble C, Williamson PR, Kirkham JJ, Reporting Bias G. Reporting Bias Group. Systematic review of the empirical evidence of study publication bias and outcome reporting bias - an updated review. PLoS One 2013;8:e66844. doi:10.1371/journal.


10 Boffetta P, McLaughlin JK, La Vecchia C, Tarone RE, Lipworth L, Blot WJ. False-positive results in cancer epidemiology: a plea for epistemological modesty. J Natl Cancer Inst 2008;100:988-95. doi:10.1093/jnci/djn191.

11 Tsilidis KK, Kasimis JC, Lopez DS, Ntzani EE, Ioannidis JP. Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies. BMJ 2015; 350:g7607. doi:10.1136/bmj.g7607.

12 Ioannidis JP. Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses. CMAJ 2009; 181:488-93. doi:10.1503/cmaj.081086.

13 Markozannes G, Tzoulaki I, Karli D, et al. Diet, body size, physical activity and risk of prostate cancer: An umbrella review of the evidence. Eur J Cancer 2016; 69:61-9. doi:10.1016/j.ejca.2016.09.026.

14 Belbasis L, Savvidou MD, Kanu C, Evangelou E, Tzoulaki I. Birth weight in relation to health and disease in later life: an umbrella review of systematic reviews and meta-analyses. BMC Med 2016; 14:147. doi:10.1186/s12916-016-0692-5.

15 Bellou V, Belbasis L, Tzoulaki I, Evangelou E, Ioannidis JP. Environmental risk factors and Parkinson’s disease: An umbrella review of meta-analyses. Parkinsonism Relat Disord 2016; 23:1-9. doi:10.1016/j.parkreldis.2015.12.008.

16 Belbasis L, Bellou V, Evangelou E, Ioannidis JP, Tzoulaki I. Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses. Lancet Neurol 2015; 14:263-73. doi:10.1016/S1474-4422(14)70267-4.

17 Theodoratou E, Tzoulaki I, Zgaga L, Ioannidis JP. Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ 2014;348:g2035. doi:10.1136/bmj.g2035.

18 Bellou V, Belbasis L, Tzoulaki I, Middleton LT, Ioannidis JP, Evangelou E. Systematic evaluation of the associations between environmental risk factors and dementia: An umbrella review of systematic reviews and meta-analyses. Alzheimers Dement 2016; S1552-5260(16)32853-9.

19 DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88. doi:10.1016/0197-2456(86)90046-2.

20 Cochran WG. The combination of estimates from different experiments. Biometrics 1954; 10:101-29doi:10.2307/3001666.

21 Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327:557-60. doi:10.1136/bmj.327.7414.557.

22 Ioannidis JP, Patsopoulos NA, Evangelou E. Uncertainty in heterogeneity estimates in meta-analyses. BMJ 2007; 335:914-6. doi:10.1136/bmj.39343.408449.80.

23 Riley RD, Higgins JP, Deeks JJ. Interpretation of random effects meta-analyses. BMJ 2011; 342:d549. doi:10.1136/bmj.d549.

24 Sterne JA, Sutton AJ, Ioannidis JP, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 2011; 343:d4002. doi:10.1136/bmj.d4002.

25 Ioannidis JP, Trikalinos TA. An exploratory test for an excess of significant findings. Clin Trials 2007;4: 245-53. doi:10.1177/1740774507079441.

26 Tsilidis KK, Panagiotou OA, Sena ES, et al. Evaluation of excess significance bias in animal studies of neurological diseases. PLoS Biol 2013;11:e1001609. doi:10.1371/journal.pbio.1001609.

27 Tsilidis KK, Papatheodorou SI, Evangelou E, Ioannidis JP. Evaluation of excess statistical significance in meta-analyses of 98 biomarker associations with cancer risk. J Natl Cancer Inst 2012; 104:1867-78. doi:10.1093/jnci/djs437.

28 Ioannidis JPA. Clarifications on the application and interpretation of the test for excess significance and its extensions. J Math Psychol 2013;57:184-7doi:10.1016/

29 Salanti G, Ioannidis JP. Synthesis of observational studies should consider credibility ceilings. J Clin Epidemiol 2009; 62:115-22.doi:10.1016/j.jclinepi.2008.05.014.

30 Papatheodorou SI, Tsilidis KK, Evangelou E, Ioannidis JP. Application of credibility ceilings probes the robustness of meta-analyses of biomarkers and cancer risk. J Clin Epidemiol 2015; 68:163-74. doi:10.1016/j.jclinepi.2014.09.004.

31 Ioannidis JP, Tarone R, McLaughlin JK. The false-positive to false-negative ratio in epidemiologic studies. Epidemiology 2011; 22:450-6. doi:10.1097/EDE.0b013e31821b506e.

32 Sterne JA, Davey Smith G. Sifting the evidence-what’s wrong with significance tests?BMJ 2001;322:226-31. doi:10.1136/bmj.322.7280.226.

33 Johnson VE. Revised standards for statistical evidence. Proc Natl Acad Sci U S A 2013; 110:19313-7. doi:10.1073/pnas.1313476110.

34 StataCorp. Stata Statistical Software: Release 13.StataCorp LP, 2013.

35 Alsamarrai A, Das SL, Windsor JA, Petrov MS. Factors that affect risk for pancreatic disease in the general population: a systematic review and meta-analysis of prospective cohort studies. Clin Gastroenterol Hepatol 2014;12:1635-44.e5, quiz e103. doi:10.1016/j.cgh.2014.01.038.

36 Amadou A, Ferrari P, Muwonge R, et al. Overweight, obesity and risk of premenopausal breast cancer according to ethnicity: a systematic review and dose-response meta-analysis. Obes Rev 2013; 14:665-78. doi:10.1111/obr.12028.

37 Aune D, Greenwood DC, Chan DS, et al. Body mass index, abdominal fatness and pancreatic cancer risk: a systematic review and non-linear dose-response meta-analysis of prospective studies. Ann Oncol 2012;23:843-52. doi:10.1093/annonc/mdr398.

38 Aune D, Navarro Rosenblatt DA, Chan DS, et al. Anthropometric factors and ovarian cancer risk: a systematic review and nonlinear dose-response meta-analysis of prospective studies. Int J Cancer 2015;136:1888-98. doi:10.1002/ijc.29207.

39 Aune D, Navarro Rosenblatt DA, Chan DS, et al. Anthropometric factors and endometrial cancer risk: a systematic review and dose-response meta-analysis of prospective studies. Ann Oncol 2015;26:1635-48. doi:10.1093/annonc/mdv142.

40 Cao Y, Ma J. Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis. Cancer Prev Res (Phila) 2011;4:486-501. doi:10.1158/1940-6207. CAPR-10-0229.

41 Casagrande DS, Rosa DD, Umpierre D, Sarmento RA, Rodrigues CG, Schaan BD. Incidence of cancer following bariatric surgery: systematic review and meta-analysis. Obes Surg 2014; 24:1499-509. doi:10.1007/s11695-014-1276-0.

42 Castillo JJ, Ingham RR, Reagan JL, Furman M, Dalia S, Mitri J. Obesity is associated with increased relative risk of diffuse large B-cell lymphoma: a meta-analysis of observational studies. Clin Lymphoma Myeloma Leuk 2014;14:122-30. doi:10.1016/j.clml.2013.10.005.

43 Castillo JJ, Reagan JL, Ingham RR, et al. Obesity but not overweight increases the incidence and mortality of leukemia in adults: a meta-analysis of prospective cohort studies. Leuk Res 2012;36:868- 75. doi:10.1016/j.leukres.2011.12.020.

44 Chen Y, Wang X, Wang J, Yan Z, Luo J. Excess body weight and the risk of primary liver cancer: an updated meta-analysis of prospective studies. Eur J Cancer 2012;48:2137-45. doi:10.1016/j.ejca.2012.02.063.

45 Connolly BS, Barnett C, Vogt KN, Li T, Stone J, Boyd NF. A meta-analysis of published literature on waist-to-hip ratio and risk of breast cancer. Nutr Cancer 2002;44:127-38. doi:10.1207/S15327914NC4402_02.

46 Discacciati A, Orsini N, Wolk A. Body mass index and incidence of localized and advanced prostate cancer--a dose-response meta-analysis of prospective studies. Ann Oncol 2012; 23:1665-71. doi:10.1093/annonc/mdr603.

47 Harriss DJ, Atkinson G, George K, et al. C-CLEAR group. Lifestyle factors and colorectal cancer risk (1): systematic review and meta-analysis of associations with body mass index. Colorectal Dis 2009; 11:547-63. doi:10.1111/j.1463-1318.2009.01766.x.

48 Harvie M, Hooper L, Howell AH. Central obesity and breast cancer risk: a systematic review. Obes Rev 2003;4:157-73. doi:10.1046/j.1467-789X.2003.00108.x.

49 Keum N, Greenwood DC, Lee DH, et al. Adult weight gain and adiposity-related cancers: a dose-response meta-analysis of prospective observational studies. J Natl Cancer Inst 2015;107doi:10.1093/jnci/djv088.

50 Larsson SC, Wolk A. Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. Am J Clin Nutr 2007; 86:556-65.

51 Larsson SC, Wolk A. Obesity and risk of non-Hodgkin’s lymphoma: a meta-analysis. Int J Cancer 2007; 121:1564-70. doi:10.1002/ijc.22762.

52 Larsson SC, Wolk A. Obesity and the risk of gallbladder cancer: a meta-analysis. Br J Cancer 2007;96:1457-61.

53 Larsson SC, Wolk A. Body mass index and risk of non-Hodgkin’s and Hodgkin’s lymphoma: a meta-analysis of prospective studies. Eur J Cancer 2011;47:2422-30. doi:10.1016/j.ejca.2011.06.029.

54 Li JS, Han TJ, Jing N, et al. Obesity and the risk of cholangiocarcinoma: a meta-analysis. Tumour Biol 2014; 35:6831-8. doi:10.1007/s13277-014-1939-4.

55 Lin XJ, Wang CP, Liu XD, et al. Body mass index and risk of gastric cancer: a meta-analysis. Jpn J Clin Oncol 2014; 44:783-91.doi:10.1093/jjco/hyu082.

56 Ma J, Huang M, Wang L, Ye W, Tong Y, Wang H. Obesity and risk of thyroid cancer: evidence from a meta-analysis of 21 observational studies. Med Sci Monit 2015; 21:283-91. doi:10.12659/MSM.892035.



Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

Términos y condiciones de uso | Todos los derechos reservados | Copyright 1997-2022